Brookside Capital Management Llc sold 106,276 shares as the company's stock rose 39.84% with the market. The stock increased 0.63% or $0.1 during the last trading session, reaching $16. About 496,236 shares traded or 3.21% up from the average. Jacobs Levy Equity Management owns 0% invested in Epizyme, Inc. It has outperformed by 75.15% the S&P500.
Midwest Investment Management Llc decreased its stake in Ametek (AME) by 54.38% based on its latest 2017Q3 regulatory filing with the SEC. The stock was sold at an average price of $16.63, for a total value of $1,201,750.32. Principal Financial Group Inc. now owns 95,572 shares of the biopharmaceutical company's stock worth $1,443,000 after acquiring an additional 1,399 shares during the period. The stock decreased 5.73% or $0.38 during the last trading session, reaching $6.25. About 1,250 shares traded. Epizyme, Inc. (NASDAQ:EPZM) has risen 91.85% since February 10, 2017 and is uptrending. It has outperformed by 12.98% the S&P500. Zacks Investment Research downgraded Epizyme from a buy rating to a hold rating in a report on Monday, May 22nd. Therefore 25% are positive.
Analysts expect Epizyme, Inc. The rating was maintained by SunTrust with "Buy" on Friday, October 27. (NASDAQ:EPZM) earned "Buy" rating by Mizuho on Tuesday, May 10. The company was maintained on Friday, September 15 by RBC Capital Markets. (NASDAQ:EPZM) on Thursday, February 1 with "Buy" rating. The stock of Epizyme, Inc. Two analysts have rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. The stock has "Buy" rating by H.C. Wainwright on Monday, March 14. The firm has "Buy" rating given on Tuesday, January 16 by Needham. Piper Jaffray maintained Noble Energy, Inc. The rating was maintained by Oppenheimer with "Buy" on Monday, July 24. The firm has "Hold" rating by RBC Capital Markets given on Wednesday, January 17. RBC Capital Markets has "Buy" rating and $2000 target. Finally, Oppenheimer set a $26.00 target price on Epizyme and gave the stock a "buy" rating in a report on Tuesday, December 12th.
Brookside Capital Management Llc, which manages about $1.58B US Long portfolio, upped its stake in Barracuda Networks Inc (NYSE:CUDA) by 242,934 shares to 466,034 shares, valued at $11.29M in 2017Q3, according to the filing. Rhumbline Advisers grew its stake in shares of Epizyme by 2.6% in the 2nd quarter.
Since August 24, 2017, it had 1 buying transaction, and 4 insider sales for $1.11 million activity. The insider Ho Peter Tai-Ching sold $252,077. Ros Matthew also sold $1.20M worth of Epizyme, Inc.
Among 33 analysts covering Lowe's Companies Inc. (NASDAQ:EPZM) has "Market Outperform" rating given on Wednesday, March 9 by JMP Securities. Meiji Yasuda Life Ins Company holds 10,100 shares. Golub Group Inc Limited Liability Corporation, a California-based fund reported 2,800 shares.
Investors sentiment decreased to 1.46 in 2017 Q3. Its down 0.47, from 1.93 in 2017Q2. It dived, as 15 investors sold EPZM shares while 22 reduced holdings.
A number of hedge funds and other institutional investors have recently made changes to their positions in EPZM. Financial Advisers Limited Liability Company stated it has 0.01% of its portfolio in Hill-Rom Holdings, Inc. (NASDAQ:EPZM). Swiss Bank has 83,700 shares for 0% of their portfolio. Wells Fargo Communications Mn stated it has 0% of its portfolio in Epizyme, Inc. Alps Advsrs Inc owns 57,472 shares. Rhenman & Asset Management Ab invested in 0.57% or 236,293 shares. Trexquant Ltd Partnership owns 28,593 shares or 0.14% of their U.S. portfolio. Franklin Resource owns 0.01% invested in Epizyme, Inc. (NASDAQ:EPZM) or 923,400 shares. Jefferies initiated Epizyme, Inc. (NASDAQ:EPZM) for 437,849 shares. (NASDAQ:EPZM) for 1.04M shares. (NASDAQ:EPZM). Pacad Limited reported 4,000 shares or 0.02% of all its holdings.
"Epizyme announced today the closing of its public offering of 10,557,000 shares of its common stock at a price of $15.25 per share, before underwriting discounts". Deerfield owns 700,526 shares.
Investors sentiment increased to 1.35 in Q3 2017. Its up 0.25, from 1.1 in 2017Q2. It is positive, as 76 investors sold LOW shares while 406 reduced holdings. 56 funds opened positions while 151 raised stakes. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.02% in AMETEK, Inc. World Asset Mgmt holds 90,185 shares. Rock Springs Cap Ltd Partnership holds 1.19% or 1.35 million shares. Renaissance Tech Lc holds 0.01% or 230,388 shares. Bokf Na reported 0.02% of its portfolio in Noble Energy, Inc. First National Bank Of Omaha, Nebraska-based fund reported 46,561 shares. (NYSE:C) for 192,056 shares. (NYSE:NBL). Oslo Asset Management As invested 1.25% in Noble Energy, Inc. Mathes reported 78,148 shares or 2.68% of all its holdings. 7,962 are held by Perritt Management. (NYSE:AME) for 14.19 million shares. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since February 11, 2017 and is uptrending.
Among 40 analysts covering Citigroup Inc. (NASDAQ:EPZM) has "Buy" rating given on Wednesday, January 24 by Jefferies. The stock has "Buy" rating by Keefe Bruyette & Woods on Thursday, December 21. The stock of Noble Energy, Inc. (NASDAQ:EPZM) earned "Buy" rating by Mizuho on Thursday, August 6. As per Tuesday, September 5, the company rating was maintained by BMO Capital Markets.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
Vivo announces which phones will get Android 8.0 Oreo update
Meanwhile, other manufacturers like Honor have already started rolling out the Oreo update for their older devices in India. In the first phase, the update will be rolled out as a beta version to just one smartphone from the eligible devices list.